Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson’s Disease
Open Access
- 1 January 2018
- journal article
- research article
- Published by Aging and Disease in Aging and disease
- Vol. 9 (4) , 590-604
Abstract
The mitochondrion is susceptible to neurodegenerative disorders such as Parkinson's disease (PD). Mitochondrial dysfunction has been considered to play an important role in the dopaminergic degeneration in PD. However, there are no effective drugs to protect mitochondria from dysfunction during the disease development. In the present study, fucoidan, a sulfated polysaccharide derived from Laminaria japonica, was investigated and characterized for its protective effect on the dopamine system and mitochondrial function of dopaminergic neurons in a rotenone-induced rat model of PD. We found that chronic treatment with fucoidan significantly reversed the loss of nigral dopaminergic neurons and striatal dopaminergic fibers and the reduction of striatal dopamine levels in PD rats. Fucoidan also alleviated rotenone-induced behavioral deficits. Moreover, the mitochondrial respiratory function as detected by the mitochondrial oxygen consumption and the expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and nuclear transcription factor 2 (NRF2) were reduced in the substantia nigra of PD rats, which were markedly reversed by fucoidan. Oxidative products induced by rotenone were significantly reduced by fucoidan. Taken together, these results demonstrate that fucoidan possesses the ability to protect the dopamine system in PD rats. The neuroprotective effect of fucoidan may be mediated via reserving mitochondrial function involving the PGC-1α/NRF2 pathway. This study provides new evidence that fucoidan can be explored in PD therapy.Keywords
This publication has 41 references indexed in Scilit:
- Parkinson’s Disease: From Pathogenesis to PharmacogenomicsInternational Journal of Molecular Sciences, 2017
- Mitochondrial control of cell bioenergetics in Parkinson’s diseaseFree Radical Biology and Medicine, 2016
- An updated review of Parkinson's disease genetics and clinicopathological correlationsActa Neurologica Scandinavica, 2016
- Neuroprotective effect of fucoidan from Turbinaria decurrens in MPTP intoxicated Parkinsonic miceInternational Journal of Biological Macromolecules, 2016
- The genetic background of Parkinson's disease: current progress and future prospectsActa Neurologica Scandinavica, 2016
- The emerging role of Nrf2 in mitochondrial functionFree Radical Biology and Medicine, 2015
- Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectivesThe Lancet, 2014
- Mitochondrial damage controlNature, 2010
- Fucoidan protects against dopaminergic neuron death in vivo and in vitroEuropean Journal of Pharmacology, 2009
- MPTP primate model of Parkinson's disease: a mechanographic and electromyographic studyBrain Research, 1985